CN115634181A - 一种针对痤疮丙酸杆菌的抑菌组合物及其应用 - Google Patents
一种针对痤疮丙酸杆菌的抑菌组合物及其应用 Download PDFInfo
- Publication number
- CN115634181A CN115634181A CN202211384608.XA CN202211384608A CN115634181A CN 115634181 A CN115634181 A CN 115634181A CN 202211384608 A CN202211384608 A CN 202211384608A CN 115634181 A CN115634181 A CN 115634181A
- Authority
- CN
- China
- Prior art keywords
- add
- extract
- stir
- acne
- propionibacterium acnes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186427 Cutibacterium acnes Species 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 229940055019 propionibacterium acne Drugs 0.000 title claims abstract description 32
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 14
- 206010000496 acne Diseases 0.000 claims abstract description 35
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 26
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000003756 stirring Methods 0.000 claims abstract description 25
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 20
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 20
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 17
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 16
- 229940069445 licorice extract Drugs 0.000 claims abstract description 14
- 229940084038 salix alba bark extract Drugs 0.000 claims abstract description 14
- 235000011187 glycerol Nutrition 0.000 claims abstract description 13
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 10
- 229920001577 copolymer Polymers 0.000 claims abstract description 10
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 229940104261 taurate Drugs 0.000 claims abstract description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 10
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 claims abstract description 10
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 9
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 9
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 9
- 229960000458 allantoin Drugs 0.000 claims abstract description 9
- 239000008367 deionised water Substances 0.000 claims abstract description 9
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 9
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 9
- BONNRKLSQRLNHV-UHFFFAOYSA-N n-methylmethanamine;prop-2-enamide Chemical compound CNC.NC(=O)C=C BONNRKLSQRLNHV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000230 xanthan gum Substances 0.000 claims abstract description 9
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 9
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 9
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 9
- 230000003255 anti-acne Effects 0.000 claims abstract description 5
- 241000555712 Forsythia Species 0.000 claims description 19
- 239000000047 product Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 241000202807 Glycyrrhiza Species 0.000 claims description 6
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 6
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 6
- 238000000265 homogenisation Methods 0.000 claims description 6
- 229940010454 licorice Drugs 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000005909 Kieselgur Substances 0.000 claims description 3
- 241000899950 Salix glauca Species 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 239000000686 essence Substances 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 6
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- JJTDIRSCDLGMRU-UHFFFAOYSA-N azane;prop-2-enamide Chemical compound N.NC(=O)C=C JJTDIRSCDLGMRU-UHFFFAOYSA-N 0.000 abstract 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- JZWFDVDETGFGFC-UHFFFAOYSA-N salacetamide Chemical group CC(=O)NC(=O)C1=CC=CC=C1O JZWFDVDETGFGFC-UHFFFAOYSA-N 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 21
- 238000012360 testing method Methods 0.000 description 7
- 239000002994 raw material Substances 0.000 description 4
- 206010040882 skin lesion Diseases 0.000 description 4
- 231100000444 skin lesion Toxicity 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000193403 Clostridium Species 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 206010037888 Rash pustular Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000002910 effect on acne Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211384608.XA CN115634181B (zh) | 2022-11-07 | 2022-11-07 | 一种针对痤疮丙酸杆菌的抑菌组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211384608.XA CN115634181B (zh) | 2022-11-07 | 2022-11-07 | 一种针对痤疮丙酸杆菌的抑菌组合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115634181A true CN115634181A (zh) | 2023-01-24 |
CN115634181B CN115634181B (zh) | 2024-11-15 |
Family
ID=84948304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211384608.XA Active CN115634181B (zh) | 2022-11-07 | 2022-11-07 | 一种针对痤疮丙酸杆菌的抑菌组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115634181B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116492238A (zh) * | 2023-04-23 | 2023-07-28 | 广州集妍化妆品科技有限公司 | 预防和治疗痤疮的组合物及其应用 |
CN116850116A (zh) * | 2023-08-24 | 2023-10-10 | 广州唯我美日用品有限公司 | 一种祛痘组合物及含有该组合物的祛痘洁面乳及制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103816165A (zh) * | 2014-03-11 | 2014-05-28 | 北京德默高科医药技术有限公司 | 一种治疗痤疮的组合物 |
CN108158993A (zh) * | 2018-01-12 | 2018-06-15 | 连云港本草美汇医药科技有限公司 | 一种祛痘控油微乳凝胶剂及其制备方法与应用 |
CN108294992A (zh) * | 2018-03-31 | 2018-07-20 | 佛山文森特知识产权服务有限公司 | 一种祛痘组合物 |
CN111658590A (zh) * | 2020-07-15 | 2020-09-15 | 泉后(广州)生物科技研究院有限公司 | 一种祛痘组合物及其应用 |
-
2022
- 2022-11-07 CN CN202211384608.XA patent/CN115634181B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103816165A (zh) * | 2014-03-11 | 2014-05-28 | 北京德默高科医药技术有限公司 | 一种治疗痤疮的组合物 |
CN108158993A (zh) * | 2018-01-12 | 2018-06-15 | 连云港本草美汇医药科技有限公司 | 一种祛痘控油微乳凝胶剂及其制备方法与应用 |
CN108294992A (zh) * | 2018-03-31 | 2018-07-20 | 佛山文森特知识产权服务有限公司 | 一种祛痘组合物 |
CN111658590A (zh) * | 2020-07-15 | 2020-09-15 | 泉后(广州)生物科技研究院有限公司 | 一种祛痘组合物及其应用 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116492238A (zh) * | 2023-04-23 | 2023-07-28 | 广州集妍化妆品科技有限公司 | 预防和治疗痤疮的组合物及其应用 |
CN116492238B (zh) * | 2023-04-23 | 2024-07-30 | 广州集妍化妆品科技有限公司 | 预防和治疗痤疮的组合物及其应用 |
CN116850116A (zh) * | 2023-08-24 | 2023-10-10 | 广州唯我美日用品有限公司 | 一种祛痘组合物及含有该组合物的祛痘洁面乳及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115634181B (zh) | 2024-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10675488B2 (en) | Acne removing skin care product and preparation method thereof | |
CN115634181A (zh) | 一种针对痤疮丙酸杆菌的抑菌组合物及其应用 | |
CN110585114B (zh) | 一种调节皮肤微生物菌群的杀菌组合物及其应用 | |
CN113693979B (zh) | 一种控油祛痘组合物及其应用 | |
CN107789308A (zh) | 一种温和控油祛痘精华 | |
CN113318065B (zh) | 一种复合酸和微生态调理组合物及其制备工艺 | |
CN117137844B (zh) | 一种祛痘控油的护肤组合物及其制备方法 | |
CN113456570A (zh) | 一种祛痘组合物、祛痘啫喱及其制备方法 | |
CN113908097A (zh) | 一种祛痘组合物及其应用 | |
CN108785243A (zh) | 一种抗衰老美白祛痘霜及其制备方法 | |
CN114469829B (zh) | 一种改善皮肤痤疮、炎症的组合物及其应用 | |
CN119530099A (zh) | 一种对皮肤有益的青春双歧杆菌及其衍生物和应用 | |
CN108969455B (zh) | 一种含紫花地丁的祛痘保湿组合物及其应用 | |
CN109453081A (zh) | 一种植物与多肽复方祛痘抑菌精华的制备方法 | |
CN110339084A (zh) | 一种多肽复方祛痘抑菌精华素的配方及其制备方法 | |
CN114533578A (zh) | 一种用于祛除脓疱型痘痘的化妆品组合物及其制备工艺 | |
CN114533596A (zh) | 一种具有改善闭口粉刺的化妆品组合物及其制备工艺 | |
CN116531272B (zh) | 一种祛痘修复组合物及其制备方法和应用 | |
CN115337211B (zh) | 一种温和低敏性保湿祛痘凝胶及其制备方法 | |
CN113350255B (zh) | 一种低刺激抑菌化妆品及其制备方法 | |
CN114569506A (zh) | 一种天然活性焕颜袪痘凝胶组合物及其制备方法 | |
CN116139052A (zh) | 一种清痘控油精华液及其制备方法 | |
CN116350529A (zh) | 用于改善或维持哺乳动物皮肤健康的方法和组合物 | |
CN116115544A (zh) | 一种漂浮油珠的祛痘精华液及其制备方法 | |
CN115414301A (zh) | 一种植物去屑组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20241021 Address after: 510931 Factory Building No. 2 Lijian Second Road, Mingzhu Industrial Park, Conghua District, Guangzhou City, Guangdong Province, self compiled on the first floor and on the second floor Applicant after: Guangzhou Datang Cosmetics Co.,Ltd. Country or region after: China Address before: 2nd and 3rd Floor, No. 2, Lijian 2nd Road, Mingzhu Industrial Park, Conghua District, Guangzhou City, Guangdong Province, 510931 Applicant before: Guangzhou Dongyao Cosmetics Co.,Ltd. Country or region before: China |
|
GR01 | Patent grant | ||
GR01 | Patent grant |